Processing of Factor XII during Inflammatory Reactions

被引:15
作者
Jukema, Bernard Nico [1 ]
de Maat, Steven [1 ]
Maas, Coen [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Clin Chem & Hematol, Utrecht, Netherlands
关键词
factor XII; inflammation; bradykinin; plasmin; elastase; PLASMA CONTACT SYSTEM; MOLECULAR-WEIGHT KININOGEN; HAGEMAN-FACTOR; MAST-CELLS; IN-VIVO; MULTIPLE-SCLEROSIS; SEPTIC SHOCK; BRAIN EDEMA; ACTIVATION; BRADYKININ;
D O I
10.3389/fmed.2016.00052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The contact system was originally identified as an obsolete part of the coagulation system, but it has been repeatedly implicated in inflammatory states, such as infection, as well as in allergic-and chronic inflammatory disease. Under these conditions, there is surprisingly little evidence that factor XII (FXII) acts as a coagulation factor, and its activity appears to be mainly directed toward activation of the kallikrein-kinin system. The contact system factors interact with pathogens as well as cells of the (innate) immune system on several levels. Among others, these cells may provide negatively charged surfaces that contribute to contact activation as well as release enzymes that feed into this system. Furthermore, cellular receptors have been identified that bind contact factors at sites of inflammation. Based on the accumulated evidence, we propose a model for enzymatic crosstalk between inflammatory cells and the plasma contact system. During these reactions, FXII is enzymatically cleaved by non-contact system enzymes. This generates unactivated FXII fragments that can subsequently be rapidly activated in the fluid phase. The resulting enzyme lacks procoagulant properties, but retains its pro-inflammatory characteristic as a prekallikrein activator.
引用
收藏
页数:7
相关论文
共 59 条
[1]   The fibrin-derived γ377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease [J].
Adams, Ryan A. ;
Bauer, Jan ;
Flick, Matthew J. ;
Sikorski, Shoana L. ;
Nuriel, Tal ;
Lassmann, Hans ;
Degen, Jay L. ;
Akassoglou, Katerina .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (03) :571-582
[2]   THE ROLE OF BRADYKININ AND THE EFFECT OF THE BRADYKININ RECEPTOR ANTAGONIST ICATIBANT IN PORCINE SEPSIS [J].
Barratt-Due, Andreas ;
Johansen, Harald Thidemann ;
Sokolov, Andrey ;
Thorgersen, Ebbe Billmann ;
Hellerud, Bernt Christian ;
Reubsaet, Jan Leo ;
Seip, Knut Fredrik ;
Tonnessen, Tor Inge ;
Lindstad, Julie Katrine ;
Pharo, Anne ;
Castellheim, Albert ;
Mollnes, Tom Eirik ;
Nielsen, Erik Waage .
SHOCK, 2011, 36 (05) :517-523
[3]  
BenNasr A, 1996, MOL MICROBIOL, V20, P927
[4]  
BJORNSON HS, 1984, REV INFECT DIS, V6, pS30
[5]   ACTIVATION OF INTRINSIC BLOOD-COAGULATION BY ELLAGIC ACID - INSOLUBLE ELLAGIC ACID-METAL ION COMPLEXES ARE THE ACTIVATING SPECIES [J].
BOCK, PE ;
SRINIVASAN, KR ;
SHORE, JD .
BIOCHEMISTRY, 1981, 20 (25) :7258-7266
[6]  
BROWER MS, 1982, J BIOL CHEM, V257, P9849
[7]   Factor XII: form determines function [J].
de Maat, S. ;
Maas, C. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (08) :1498-1506
[8]   Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations [J].
de Maat, Steven ;
Bjorkqvist, Jenny ;
Suffritti, Chiara ;
Wiesenekker, Chantal P. ;
Nagtegaal, Willem ;
Koekman, Arnold ;
van Dooremalen, Sanne ;
Pasterkamp, Gerard ;
de Groot, Philip G. ;
Cicardi, Marco ;
Renne, Thomas ;
Maas, Coen .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 138 (05) :1414-+
[9]   A nanobody-based method for tracking factor XII activation in plasma [J].
de Maat, Steven ;
van Dooremalen, Sanne ;
de Groot, Philip G. ;
Maas, Coen .
THROMBOSIS AND HAEMOSTASIS, 2013, 110 (03) :458-468
[10]   Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor [J].
Dewald, G ;
Bork, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 343 (04) :1286-1289